Articles
October 09, 2012
Interchangeable Biosimilars - Time to Reform the Orange Book
Bloomberg BNA’s Pharmaceutical Law & Industry Report
September 17, 2012
Beware NPEs - ITC says no to exclusion order for an NPE who obtained ongoing royalties in district court
Fish & Richardson
August 29, 2012
CAFC affirms exclusion of allegedly comparable license and addresses marking law on method claims
Fish & Richardson
August 27, 2012
CAFC vacates unsupported reasonable royalty award in Whitserve v. CPi
Fish & Richardson
August 16, 2012
CDCA compels production of IBM cross-licenses and outbound licenses
Fish & Richardson
August 14, 2012
USPTO Releases Final Rules for Remaining AIA Provisions Going into Effect on September 16, 2012
Fish & Richardson
August 13, 2012
ND Illinois upholds lost profits verdict; denies defendants' JMOL re absence of noninfringing substitutes
Fish & Richardson
August 09, 2012
SDTX issues two orders precluding plaintiff's expert from testifying on reasonable royalty
Fish & Richardson
August 07, 2012
NDCA in Implicit v. Juniper hears renewed MTC and orders production of license negotiations
Fish & Richardson
July 11, 2012
Attempted sales price of patent-in-suit relevant to reasonable royalties
Fish & Richardson
July 06, 2012
NDCA refuses to compel production of license negotiations and license drafts
Fish & Richardson
IP Law Essentials
-
What is the first step in the patent litigation process? What's a Markman hearing? Can you be sued at the International Trade Commission? Our IP Law Essentials series answers these questions and many more, providing a thorough introduction to IP law from some of the world's premier IP practitioners.